Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NeuroPace (NPCE) Non Operating Income (2020 - 2025)

Historic Non Operating Income for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $82000.0.

  • NeuroPace's Non Operating Income fell 6255.71% to $82000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$572000.0, marking a year-over-year decrease of 18732.82%. This contributed to the annual value of $304000.0 for FY2024, which is 19650.79% up from last year.
  • Per NeuroPace's latest filing, its Non Operating Income stood at $82000.0 for Q3 2025, which was down 6255.71% from -$486000.0 recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Non Operating Income registered a high of $265000.0 during Q4 2023, and its lowest value of -$3.1 million during Q1 2021.
  • Moreover, its 5-year median value for Non Operating Income was -$82000.0 (2025), whereas its average is -$327105.3.
  • The largest annual percentage gain for NeuroPace's Non Operating Income in the last 5 years was 28150.68% (2023), contrasted with its biggest fall of 2713333.33% (2023).
  • NeuroPace's Non Operating Income (Quarter) stood at -$2000.0 in 2021, then crashed by 7200.0% to -$146000.0 in 2022, then skyrocketed by 281.51% to $265000.0 in 2023, then plummeted by 132.45% to -$86000.0 in 2024, then surged by 195.35% to $82000.0 in 2025.
  • Its Non Operating Income was $82000.0 in Q3 2025, compared to -$486000.0 in Q2 2025 and -$82000.0 in Q1 2025.